NeuroNexus is a fast-growing neurotechnology company that develops and commercializes high-value neural interface technology, components, systems, and software for neuroscience and clinical applications.
Originally developed at the University of Michigan, NeuroNexus’ suite of commercialized technologies has, for over a decade, led to hundreds of publications from research labs all around the world. Our products include conventional and high-density leads, recording and stimulation systems, and software for data analytics. Our products have been used in a wide variety of animal models from fruit fly to rodent to non-human primates. NeuroNexus is currently working to make our state-of-the-art technologies and systems available for human clinical research.
NeuroNexus’ proprietary microelectronic, fluidic, and optical technology is used to “map” brain function, detect neural activity, and stimulate or modulate neural circuits when brain function is impaired.
NeuroNexus is a subsidiary of Nuvectra, and is located in Ann Arbor, Michigan, USA.